Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, February 2000, p. 311-315, Vol. 44, No. 2
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Substitutions in the Eyelet Region Disrupt Cefepime
Diffusion through the Escherichia coli OmpF
Channel
Valérie
Simonet,
Monique
Malléa, and
Jean-Marie
Pagès*
CJF 9606, Faculté de Médecine,
13385 Marseille Cedex 05, France
Received 19 March 1999/Returned for modification 14 September
1999/Accepted 1 November 1999
 |
ABSTRACT |
The Escherichia coli OmpF porin is a nonspecific
channel involved in the membrane translocation of small hydrophilic
molecules and especially in the passage of
-lactam antibiotics. In
order to understand the dynamic of charged-compound uptake through
bacterial porins, specific charges located in the E. coli
OmpF channel were mutated. Substitutions G119D and G119E, inserting a
protruding acidic side chain into the pore, decreased cephalosporin and
colicin susceptibilities. Cefepime diffusion was drastically altered by these mutations. Conversely, substitutions R132A and R132D, changing a
residue located in the positively charged cluster, increased the rate
of cephalosporin uptake without modifying colicin sensitivity. Modelling approaches suggest that G119E generates a transverse hydrogen
bond dividing the pore, while the two R132 substitutions stretch the
channel size. These charge alterations located in the constriction area
have differential effects on cephalosporin diffusion and substantially
modify the profile of antibiotic susceptibility.
 |
INTRODUCTION |
The outer membrane of gram-negative
bacteria shelters them from external toxic compounds. In the membrane,
porins are channel-forming proteins allowing diffusion of small
hydrophilic solutes through this barrier (10, 18, 20). With
bacterial resistance to various antibiotics due to the permeability
barrier impairing chemotherapy (19), it is important to
define the biochemical and biophysical parameters governing target
access and intracellular drug concentration. In particular, since outer
membrane porins are key to
-lactam penetration (19, 22),
it is essential to understand the various possible interactions. The
native Escherichia coli OmpF porin is a trimer, and the
three-dimensional structure shows a monomeric
-barrel built of 16 antiparallel
-strands containing the pore (6). The
longest loop, L3, is bent into the channel, forming a gate; in this
constriction area, a positively charged cluster of amino acid residues
protruding from the barrel wall faces the L3 negatively charged side
chain residues. This generates a strong electrostatic field parallel to
the membrane surface, and such an organization could facilitate the
diffusion of molecules and modulate voltage gating (6, 12,
36). Several mutations have been selected on residues located in
the channel; among them, G119D is a substitution located in L3 obtained
from colicin N resistance screening after random mutagenesis
(8). Structural and functional analyses of the G119D porin
indicate that the mutation affects channel properties without causing
large molecular alterations (11). To address the question of
the effects of steric hindrance and charge movement in the flux through
the pore lumen, mutant porins with site-specific mutations in positions 119 and 132 have been constructed: 119D and 119E, which are located in
the negatively charged cluster, and 132A and 132D, which belong to the
facing positive region. Using immunological probes directed against
wild-type porin, we established the correct membrane insertion of the
various modified molecules. The activities of antibacterial compounds
and the kinetics of labeled antibiotic uptake demonstrated the role of
amino acid residues in diffusion through the channel. Protein modelling
addressed the substitution effect on the pore and illustrated the
interaction between the porin lumen and cephalosporin.
(This work was presented in part at the 38th Interscience Conference on
Antimicrobial Agents and Chemotherapy, San Diego, Calif., 24 to 27 September 1998.)
 |
MATERIALS AND METHODS |
Bacterial strains, plasmids, media, and site-directed mutagenesis
of the ompF gene.
The E. coli strains used
in this work were AK101 (rnhA::cat
derivative of JM101) (23)), DH5
mutS (DH5
mutS::Tn10) (27), and BZB1107
(ompF::Tn5) derived from the wild-type E. coli BE from the Biozentrum (Basel, Switzerland)
collection (27). Enterobacter cloacae 201-RevM3,
devoid of porin, was also used (17). Plasmids pLG361,
encoding wild-type OmpF, and pBSK(+/
) Urnh, which can replicate only
into AK101 cells due to its defective ori, have been
described elsewhere (4, 8).
Bacteria were routinely grown in Luria-Bertani (LB) medium at 37°C
with gentle shaking. If required, kanamycin (50 µg/ml), ampicillin
(50 µg/ml), tetracycline (15 µg/ml), and chloramphenicol (60 µg/ml) (Sigma) were added.
The amino acid residues located in the constriction area of the
E. coli ompF channel were replaced by the site-directed
mutagenesis method as described by Ohmori (23). A 918-bp
BglII-ClaI fragment of the ompF gene
was excised from pLG361 and inserted into the BamHI and
ClaI sites of the pBSK Urnh vector to give
pBSK-ompF. This plasmid was used to transform E. coli AK101. pBSK-ompF single-stranded DNA was isolated
using R408 helper phage (31). The mutations were created by
the method of Ohmori (23) and confirmed by DNA sequencing.
The plasmid was transformed into DH5
mutS. The
BstYI-ClaI fragments carrying the various
mutations were excised from pBSK-ompF and cloned into the
pLG361 expression vector between the BglII and
ClaI sites to give pVAV1, pVAV2, pVAV3, and pVAV4, encoding substitutions G119D, G119E, R132A, and R132D, respectively. These plasmids were used to transform BZB1107 or E. cloacae
201-RevM3 cells.
Antibiotic and colicin susceptibility tests.
For the
determination of MICs, approximately 106 cells were
inoculated into 1 ml of Mueller-Hinton broth containing twofold serial
dilutions of each antibiotic, and the results were read after 18 h
at 37°C (5).
Colicin N was purified from strain BZB1019(pCHAP4) (28). It
was assayed with cells grown in LB medium. One hundred microliters of
cell suspension at an optical density of 0.5 at 600 nm was added to
various dilutions (10
1 to 10
6) of colicin N
(1.0 mg/ml) in phosphate buffer (150 mM NaCl, 3 mM KCl, 1 mM
KH2PO4, 10 mM Na2HPO4,
pH 7) and incubated for 20 min at 37°C. The cell suspension was then
diluted with 15 volumes of fresh LB medium. The percentage of surviving
cells with or without bacteriocin treatment was monitored after 2 h at 37°C by determining the ratio of the optical densities at 600 nm
(11).
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and
porin immunocharacterization.
Exponential-phase bacteria in LB
broth were pelleted and solubilized in loading buffer (160 mM Tris, 0.8 M sucrose, 0.01% bromophenol blue, 3% sodium dodecyl sulfate, 1%
2-mercaptoethanol) at 96°C. Samples (an amount corresponding to 0.02 optical density unit at 600 nm) were loaded on sodium dodecyl
sulfate-polyacrylamide gels (10% polyacrylamide, 0.1% sodium dodecyl
sulfate) as described previously (8) and then
electrotransferred to nitrocellulose membranes. An initial saturating
step with TBS (50 mM Tris-HCl, 150 mM NaCl, pH 8) containing 10%
(wt/vol) skim milk was carried out overnight at 4°C. The
nitrocellulose membranes were then incubated in TBS containing 10%
skim milk and 0.2% Triton X-100 for 2 h at room temperature in
the presence of polyclonal antibodies directed against denatured OmpF
(8). After four washings in the same buffer, detection was
performed with alkaline phosphatase-conjugated AffinitiPure goat
anti-rabbit immunoglobulin G antibodies (Jackson ImmunoResearch, West
Grove, Pa.) as described previously (5).
For immunodotting detection, equivalent amounts of bacteria expressing
the various OmpF porins from exponential cell cultures were loaded on
nitrocellulose. Immunodetections were carried out in TBS containing
10% skim milk with two monoclonal antibodies (MoF 18 and 19) directed
against cell surface-exposed monomeric epitopes located on the subunit,
with a monoclonal antibody (MoF 21) specific to a cell surface-exposed
trimeric epitope, and with polyclonal antibodies directed against cell
envelope (15). After four washings in the same buffer,
detection was carried out with alkaline phosphatase-conjugated
AffinitiPure anti-mouse antibodies (Jackson ImmunoResearch) (8,
15).
Measurement of cefepime uptake.
E. cloacae 201-RevM3
(17), an isolate devoid of porins, was selected as the
recipient strain for the various constructs and wild-type OmpF.
Exponential-phase bacteria in nutrient broth were removed by
centrifugation, and pellets were resuspended in sodium phosphate buffer
(50 mM, pH 7), supplemented with 5 mM MgCl2, to a density
of 3 × 106 CFU/ml. Fifty microliters, containing 50 nM 14C-labeled cefepime (a gift from Bristol-Myers Squibb,
Syracuse, N.Y.) mixed with unlabeled cefepime (final specific activity, 25.4 µCi/mg), was added to a 450-µl cell suspension at 37°C in a
shaking water bath. At set intervals, samples were mixed with 7% cold
trichloroacetic acid as described by Lee et al. (13). After
10 min on ice, samples were filtered through GF/C filters (Whatman LTD,
Maidstone, England), washed twice, and dried. The radioactivity was
measured in a Packard scintillation spectrophotometer.
Protein modelling.
The protein modelling was carried out by
Synt:em (Nimes, France). The frame structures used for modelling were
wild-type OmpF (6) and the mutants R42C, R82C, G119D, D113G,
and deletion 109-114 (11, 14, 26, 29). These structures were
analyzed with the COMPOSER program (3) to search the
structurally conserved area (24, 30). The flexible part was
analyzed by AMBER treatment with the SYBYL 6.4 program (24).
 |
RESULTS |
Folding and stability of OmpF mutants.
The folding and
membrane locations of the mutated porins were checked by immunodotting
of bacteria containing the various plasmids (Fig.
1). The signals obtained with monoclonal
antibodies recognizing monomeric epitopes (Fig. 1, rows A and B)
indicated similar expression and antigenic accessibility of the various modified porins at the cell surface compared to wild-type OmpF. In
addition, the probe specific to a cell surface-exposed trimeric epitope
clearly indicated the correct folding of modified porins in the outer
membrane (Fig. 1, row C). The amounts of the OmpF mutants were roughly
equal to that of the wild-type porin, and the monomers issued from
these constructs had an electrophoretic mobility different from that of
wild-type OmpF (data not shown). It has been previously reported that
some mutated or chimeric porins have reduced thermal stability,
especially when the modification or the fusion site mapped on residues
neighboring the channel constriction area or in the L2 loop (7, 8,
25). The 119E trimer was strongly heat sensitive; the trimeric
form was observed only at 50°C and was completely dissociated at
55°C. Only a 5°C shift distinguished the 119E and 119D trimer
stabilities (Table 1). In contrast, 132D
and to a greater extent 132A were markedly less affected by the
temperature, suggesting that no perturbation occurred during trimer
arrangement.

View larger version (51K):
[in this window]
[in a new window]
|
FIG. 1.
Folding and locations of the various constructs.
Immunodetections were carried out with two monoclonal antibodies
directed against epitopes located on the monomeric form (rows A and B),
with a monoclonal antibody specific to a trimeric epitope (C), and with
polyclonal antibodies directed against cell envelope (D). Lanes: 0, E. coli BZB1107, devoid of porin; WT, BZB1107 (pLG361),
encoding the wild-type OmpF; 119D, 119E, 132A, and 132D, BZB1107
expressing the various mutants.
|
|
Colicin and antibiotic susceptibilities.
Resistance of the
G119D mutant to colicin N, which requires only OmpF to bind and enter
the bacterial cell, has been previously reported (8, 11).
Consequently, it was of interest to determine the levels of colicin N
sensitivity for the various porins. Substitutions located at position
119 conferred greater colicin resistance (Table 2). Moreover, the colicin sensitivity of
the bacterial cells expressing the 119E substitution was decreased by a
factor of 10 relative to that for 119D. Mutations 132A and 132D did not significantly modify the colicin N susceptibility of producing cells
(Table 2).
A panel of antibiotics was used to test susceptibilities of strains
expressing the various mutants. The strongest modifications, reflected
by the increase of MICs, affected cephem activities (Table 2).
Mutations located at residue 119 conferred the greater resistance
profile. This resistance concerned all of the tested cephalosporins
whatever their global charge, with some of the tested molecules being
monoanionic, zwitterionic, or dianionic (21, 24). Mutation
132A or 132D did not significantly change the cephalosporin
sensitivity, except for the dianionic moxalactam with 132A.
Cefepime diffusion.
We analyzed the uptake of radiolabeled
cefepime by using E. cloacae cells (Fig.
2). When the wild-type OmpF was
synthesized, a linear rate was observed during the first 60 s and
the steady-state level was reached at about 1.5 to 2 min. This cefepime
accumulation reflected the functional porin, while no significant
uptake was obtained in the absence of porin. Diffusion of radiolabeled
cefepime was drastically impaired for cells expressing mutations 119D
or 119E, indicating a strong alteration of channel properties (Fig. 2).
Interestingly, the extension of the side chain, induced by the D
E
transition, did not markedly change the level of cefepime diffusion. In
contrast, when bacteria expressed the 132D or 132A substitution, the
initial rate of cefepime uptake was appreciably increased without
modification of the steady-state level.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 2.
Cefepime diffusion through the various porins. Values
are means of three independent determinations. E. cloacae
isolate 201-RevM3, which is devoid of porins, and 201-RevM3 expressing
wild-type OmpF or the 119D, 119E, 132D, or 132A mutant were used.
|
|
Protein modelling.
In the case of the 119E mutant, and taking
into account the energetic hindrances in this area, the longer side
chain of glutamic acid relative to aspartic acid generated a hydrogen
bond with R82 (Fig. 3). This transverse
bond could definitively separate the channel into two smaller
compartments, as previously observed for the three-dimensional
structure of the 119D mutant (11). Interestingly, three
distances between residues located in the constriction area, d1
(between residues 42 and 119), d2 (between residues 82 and 119), and d3
(between residues 119 and 132), were lower than those of wild-type
porin: 50, 55, and 50%, respectively, with the 119D substitution and
45, 39, and 35%, respectively, with the 119E substitution. With the
substitutions located at R132, no significant modification in d1 or d2
was observed, while a noticeable increase in d3 (110 to 127%) compared
with that in wild-type OmpF was obtained. These data suggested that
132A and 132D, in addition to the charge modification, stretch the
channel, generating an increase of the cavity.

View larger version (68K):
[in this window]
[in a new window]
|
FIG. 3.
Representation of the various porins. Molecules are
viewed from the periplasmic space, and only residues 82, 102, 119, and
132 are indicated for clarity. d1, d2, and d3 illustrate the intervals
between residues 119 to 42, 119 to 82, and 119 to 132, respectively,
which are used to evaluate the induced deviation.
|
|
 |
DISCUSSION |
Various OmpF site-specific mutants were analyzed to investigate
the role of charged residues located in the porin constriction area in
the diffusion rate of hydrophilic compounds. In 119E substitution, compared to 119D, the conservation of negative charge is associated with a CH2 extension of the side chain favoring a
transverse hydrogen bond with R82. The previous X-ray data indicated
that 119D generates only local effects (11). The crystal
structure of the colicin N fragment suggests a model for its
translocation (35). The results support the role of the L3
loop in conjunction with the colicin translocation domain during
bacteriocin uptake through the membrane. The redistribution of charged
side chains due to the hydrogen bond 119E-R82 inhibited the penetration
of colicin into the periplasm. Moreover, the presence of negatively
charged residues in the porin channel was sufficient per se to decrease cephalosporin sensitivity. The initial rate of cefepime diffusion was
seriously affected, with reductions of flux of 8- to 10-fold for 119D
and 119E. Of significant importance is that the zwitterionic cefepime
will presumably form one or several salt bridges during diffusion.
Taking into account the modelling of mutations at position 119 and the
distribution of charges inside the channel (12, 26, 33, 36),
a strong deviation of the bulky cefepime, which is a very large
molecule relative to pore diameter (1), probably occurred
through the newly orientated electrostatic field.
The 132A substitution eliminated the hydrogen bond with Y102 residue
and released this position from the positively charged cluster, while
the 132D substitution preserved a hydrogen bond with Y102. In two
cases, no significant modification in the colicin activity was
observed. These two substitutions speeded up the diffusion of cefepime.
The previous studies on OmpF mutants selected for larger pore size,
which reported the modification of electrical properties of mutant
porin channels (2, 14, 29), are worth mentioning.
Substitution R42C or R132P, removing the charged side chain, had a more
cation-selective pore and a decreased critical voltage. The increase of
cefepime uptake with mutants 132A and 132D indicated that the guanidium
group of R132 plays an important role in the cephalosporin orientation
through the native eyelet. In the case of PhoE, the substitution
removing the R residue in position 37 or 75 (equivalent to positions 42 and 82 in OmpF, respectively), distally located to R132, increases the
rate of uptake of cephaloridine (34). However, this is a
small zwitterionic cephalosporin compared to cefepime used in this
study (1, 20, 21, 37).
This concept is especially important with the increasing bacterial
resistance conferred by modification of membrane permeability (19). A recently isolated clinical strain of E. aerogenes (16) producing an altered porin had
characteristics similar to those of the in vitro-designed mutants
described here. In addition, Gill et al. (9) reported the
existence of discrete mutations in the Neisseria gonorrhoeae
porin that increased the negative charge in the putative gonococcal
equivalent of E. coli loop 3. These substitutions were
associated with a noteworthy
-lactam resistance found in clinical
isolates. Recently, molecular dynamic studies of the OmpF pore that
focused on the constriction zone supported an active role for the ionic
environment of the charged residues located inside the channel
(32, 33). In this context, the location of our selected
substitutions is essential: the effects reported here illustrate the
putative role of the opposite charges in the pore eyelet as
orientation-determining regions for charged compounds such as cephalosporins.
 |
ACKNOWLEDGMENTS |
We thank D. Fourel, V. Géli, B. I. Holland, and F. Pattus for the generous gifts of colicins and plasmids. We gratefully acknowledge H. Bénédetti, J.-M. Bolla, and J. Chevalier for helpful advice. We thank Bristol-Myers Squibb for its
generous gift of radiolabeled cefepime.
This work was supported by the Institut National de la Santé et
de la Recherche Médicale, the Fondation pour la Recherche Médicale, the Université de la Méditerranée,
and the Région PACA and Marseille-Métropole.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: CJF 9606 INSERM,
Faculté de Médecine, Université de la
Méditerranée, 27 Boulevard Jean Moulin, 13385 Marseille
Cedex 05, France. Phone: 33 4 91 32 45 87. Fax: 33 4 91 32 46 06. E-mail: Jean-Marie.Pages{at}medecine.univ-mrs.fr.
 |
REFERENCES |
| 1.
|
Bellido, F.,
J. C. Pechère, and R. E. W. Hancock.
1991.
Reevaluation of the factors involved in the efficacy of new -lactams against Enterobacter aerogenes.
Antimicrob. Agents Chemother.
35:73-78[Abstract/Free Full Text].
|
| 2.
|
Benson, S. A.,
J. L. L. Occi, and B. A. Sampson.
1988.
Mutations that alter the pore function of the OmpF porin of Escherichia coli K-12.
J. Mol. Biol.
203:961-970[CrossRef][Medline].
|
| 3.
|
Bernstein, F.,
T. F. Koetzle,
G. Williams,
E. F. Meyer,
M. D. Brice,
J. R. Rodgers,
O. Kennard,
T. Shimanouchi, and M. Tasumi.
1977.
The protein data bank: a computer-based archival file for macromolecular structures.
J. Mol. Biol.
112:535-542[Medline].
|
| 4.
|
Bouveret, E.,
A. Rigal,
C. Lazdunski, and H. Benedetti.
1998.
Distinct regions of the colicin A translocation domain are involved in the interaction with Tol A and Tol B proteins upon import into Escherichia coli.
Mol. Microbiol.
27:143-157[CrossRef][Medline].
|
| 5.
|
Charrel, R. N.,
J.-M. Pagès,
P. De Micco, and M. Malléa.
1996.
Prevalence of outer membrane porin alteration in -lactam-antibiotic-resistant Enterobacter aerogenes.
Antimicrob. Agents Chemother.
40:2854-2858[Abstract].
|
| 6.
|
Cowan, S. W.,
T. Schirmer,
G. Rummel,
M. Steiert,
R. Ghosh,
R. A. Pauptit,
J. A. Jansonius, and J. P. Rosenbusch.
1992.
Crystal structures explain functional properties of two E. coli porins.
Nature
358:727-733[CrossRef][Medline].
|
| 7.
|
Fourel, D.,
A. Bernadac, and J.-M. Pagès.
1994.
Involvement of exposed polypeptide loops in trimeric and membrane insertion of Escherichia coli OmpF porin.
Eur. J. Biochem.
222:625-630[Medline].
|
| 8.
|
Fourel, D.,
S. Mizushima,
A. Bernadac, and J.-M. Pagès.
1993.
Specific regions of Escherichia coli OmpF protein involved in antigenic and colicin receptor sites and in stable trimerization.
J. Bacteriol.
175:2754-2757[Abstract/Free Full Text].
|
| 9.
|
Gill, M. J.,
S. Simjee,
K. Al-Hattawi,
B. D. Robertson,
C. S. F. Easmon, and C. A. Ison.
1998.
Gonococcal resistance to -lactams and tetracycline involves mutation in loop 3 of the porin encoded at the penB locus.
Antimicrob. Agents Chemother.
42:2799-2803[Abstract/Free Full Text].
|
| 10.
|
Hancock, R. E. W.
1997.
The bacterial outer membrane as a drug barrier.
Trends Microbiol.
5:37-42[CrossRef][Medline].
|
| 11.
|
Jeanteur, D.,
T. Schirmer,
D. Fourel,
V. Simonet,
G. Rummel,
J. P. Rosenbusch, and J.-M. Pagès.
1994.
Structural and functional alterations of a colicin resistant mutant of OmpF from E. coli.
Proc. Natl. Acad. Sci. USA
91:10675-10679[Abstract/Free Full Text].
|
| 12.
|
Karshikoff, A.,
S. W. Cowan,
V. Spassov,
R. Ladenstein, and T. Schirmer.
1994.
Electrostatic properties of two porin channels from E. coli.
J. Mol. Biol.
240:372-384[CrossRef][Medline].
|
| 13.
|
Lee, E. H.,
M. H. Nicolas,
M. D. Kitzis,
G. Pialoux,
E. Collatz, and L. Gutmann.
1991.
Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem.
Antimicrob. Agents Chemother.
35:1093-1098[Abstract/Free Full Text].
|
| 14.
|
Lou, K. L.,
N. Saint,
A. Prilipov,
G. Rummel,
S. A. Benson,
J. P. Rosenbusch, and T. Schirmer.
1996.
Structural and functional characterization of OmpF porin mutants selected for larger pore size. Crystallographic analysis.
J. Biol. Chem.
271:20669-20675[Abstract/Free Full Text].
|
| 15.
|
Lupi, N.,
A. Bourgois,
A. Bernadac,
S. Laboucarié, and J.-M. Pagès.
1989.
Immunological analysis of porin polymorphism in Escherichia coli B and K-12.
Mol. Immunol.
26:1027-1036[CrossRef][Medline].
|
| 16.
|
Malléa, M.,
J. Chevalier,
C. Bornet,
A. Eyraud,
A. Davin-Regli,
C. Bollet, and J.-M. Pagès.
1998.
Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes.
Microbiology
144:3003-3009[Abstract].
|
| 17.
|
Malléa, M.,
V. Simonet,
L. Eun-Hee,
E. Collatz,
R. Gervier,
L. Gutmann, and J.-M. Pagès.
1995.
Biological and immunological comparisons of Enterobacter cloacae and Escherichia coli porins.
FEMS Microbiol. Lett.
129:273-280[Medline].
|
| 18.
|
Nikaido, H.
1994.
Porins and specific diffusion channels in bacterial outer membranes.
J. Biol. Chem.
269:3905-3908[Free Full Text].
|
| 19.
|
Nikaido, H.
1994.
Prevention of drug access to bacterial targets: permeability barriers and active efflux.
Science
264:382-388[Abstract/Free Full Text].
|
| 20.
|
Nikaido, H.
1996.
Outer membrane, p. 29-47.
In
F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology. ASM Press, Washington, D.C.
|
| 21.
|
Nikaido, H.,
W. Liu, and E. Y. Rosenberg.
1990.
Outer membrane permeability and -lactamase stability of dipolar ionic cephalosporins containing methoxyimino substituents.
Antimicrob. Agents Chemother.
34:337-342[Abstract/Free Full Text].
|
| 22.
|
Nikaido, H., and S. Normark.
1987.
Sensitivity of Escherichia coli to various -lactams is determined by the interplay of outer membrane permeability and degradation by periplasmic -lactamases: a quantitative predictive treatment.
Mol. Microbiol.
1:29-36[CrossRef][Medline].
|
| 23.
|
Ohmori, H.
1994.
A new method for strand discrimination in sequence-directed mutagenesis.
Nucleic Acids Res.
22:884-885[Free Full Text].
|
| 24.
|
Pearlman, D. A.,
D. A. Case,
J. W. Caldwell,
W. S. Ross,
T. E. Cheatham,
D. M. Ferguson,
G. L. Seibel,
U. Chandra Singh,
P. K. Keiner, and P. A. Kollman.
1995.
AMBER 4.1.
University of California, San Franscisco.
|
| 25.
|
Phale, P. S.,
A. Philippsen,
T. Kiefhaber,
R. Koebnik,
V. P. Phale,
T. Schirmer, and J. P. Rosenbusch.
1998.
Stability of trimeric OmpF porin: the contribution of the latching loop L2.
Biochemistry
37:15663-15670[CrossRef][Medline].
|
| 26.
|
Phale, P. S.,
T. Schirmer,
A. Prilipov,
A. Hardmeyer, and J. P. Rosenbusch.
1997.
Voltage gating of E. coli porin channels: role of the constriction loop.
Proc. Natl. Acad. Sci. USA
94:6741-6745[Abstract/Free Full Text].
|
| 27.
|
Prilipov, A.,
P. S. Phale,
P. Van Gelder,
J. P. Rosenbusch, and R. Koebnik.
1998.
Coupling site-directed mutagenesis with high-level expression: large scale production of mutant porins from E. coli.
FEMS Microbiol. Lett.
163:65-72[CrossRef][Medline].
|
| 28.
|
Pugsley, A. P.
1987.
Nucleotide sequencing of the structural gene for colicin N reveals homology between the catalytic, C-terminal domains of colicins A and N.
Mol. Microbiol.
1:317-325[CrossRef][Medline].
|
| 29.
|
Saint, N.,
K. L. Lou,
C. Widmer,
M. Luckey,
T. Schirmer, and J. P. Rosenbusch.
1996.
Structural and functional characterization of OmpF porin mutants selected for larger pore size. Functional characterization.
J. Biol. Chem.
271:20676-20680[Abstract/Free Full Text].
|
| 30.
|
Sali, A., and T. Blundell.
1995.
Comparative protein modelling by satisfaction of spatial restraints.
J. Mol. Biol.
234:779-815.
|
| 31.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 32.
|
Suenaga, A.,
Y. Komeiji,
M. Uebayasi,
T. Meguro,
M. Saito, and I. Yamato.
1998.
Computational observation of an ion permeation through a channel protein.
Biosci. Rep.
18:39-48[CrossRef][Medline].
|
| 33.
|
Tieleman, D. P., and H. J. C. Berendsen.
1998.
A molecular dynamics study of the pores formed by Escherichia coli OmpF porin in a fully hydrated palmitoyloleoylphosphatidylcholine bilayer.
Biophys. J.
74:2786-2801[Abstract/Free Full Text].
|
| 34.
|
van Gelder, P.,
N. Saint,
P. Phale,
E. F. Eppens,
A. Prilipov,
R. van Boxtel,
J. P. Rosenbusch, and J. Tommassen.
1997.
Voltage sensing in the PhoE and OmpF outer membrane porins of Escherichia coli: role of charged residues.
J. Mol. Biol.
269:468-472[CrossRef][Medline].
|
| 35.
|
Vetter, I. R.,
M. W. Parker,
A. D. Tucker,
J. H. Lakey,
F. Pattus, and D. Tsernoglou.
1998.
Crystal structure of a colicin N fragment suggests a model for toxicity.
Structure
6:863-874[Medline].
|
| 36.
|
Watanabe, M.,
J. P. Rosenbusch,
T. Schirmer, and M. Karplus.
1997.
Computer simulations of the OmpF porin from the outer membrane of Escherichia coli.
Biophys. J.
72:2094-2102[Abstract/Free Full Text].
|
| 37.
|
Yoshimura, F., and H. Nikaido.
1985.
Diffusion of -lactam antibiotics through the porin channels of E. coli K-12.
Antimicrob. Agents Chemother.
27:84-92[Abstract/Free Full Text].
|
Antimicrobial Agents and Chemotherapy, February 2000, p. 311-315, Vol. 44, No. 2
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Pagel, M., Simonet, V., Li, J., Lallemand, M., Lauman, B., Delcour, A. H.
(2007). Phenotypic Characterization of Pore Mutants of the Vibrio cholerae Porin OmpU. J. Bacteriol.
189: 8593-8600
[Abstract]
[Full Text]
-
Danelon, C., Nestorovich, E. M., Winterhalter, M., Ceccarelli, M., Bezrukov, S. M.
(2006). Interaction of Zwitterionic Penicillins with the OmpF Channel Facilitates Their Translocation. Biophys. J
90: 1617-1627
[Abstract]
[Full Text]
-
Ceccarelli, M., Danelon, C., Laio, A., Parrinello, M.
(2004). Microscopic Mechanism of Antibiotics Translocation through a Porin. Biophys. J
87: 58-64
[Abstract]
[Full Text]
-
Nestorovich, E. M., Rostovtseva, T. K., Bezrukov, S. M.
(2003). Residue Ionization and Ion Transport through OmpF Channels. Biophys. J
85: 3718-3729
[Abstract]
[Full Text]
-
Armand-Lefevre, L., Leflon-Guibout, V., Bredin, J., Barguellil, F., Amor, A., Pages, J. M., Nicolas-Chanoine, M.-H.
(2003). Imipenem Resistance in Salmonella enterica Serovar Wien Related to Porin Loss and CMY-4 {beta}-Lactamase Production. Antimicrob. Agents Chemother.
47: 1165-1168
[Abstract]
[Full Text]
-
Nestorovich, E. M., Danelon, C., Winterhalter, M., Bezrukov, S. M.
(2002). Designed to penetrate: Time-resolved interaction of single antibiotic molecules with bacterial pores. Proc. Natl. Acad. Sci. USA
99: 9789-9794
[Abstract]
[Full Text]
-
Aubert, D., Poirel, L., Chevalier, J., Leotard, S., Pages, J.-M., Nordmann, P.
(2001). Oxacillinase-Mediated Resistance to Cefepime and Susceptibility to Ceftazidime in Pseudomonas aeruginosa. Antimicrob. Agents Chemother.
45: 1615-1620
[Abstract]
[Full Text]